Netupitant/palonosetron (NEPA; Akynzeo®) combination in prevention of the nausea and vomiting in patients with breast cancer receiving anthracyclinbased chemotherapy

Netupitant/palonosetron (NEPA; Akynzeo®) combination in prevention of the nausea and vomiting in patients with breast cancer receiving anthracyclinbased chemotherapy

Chemotherapy-induced nausea and vomiting is a common problem during cancer treatment, especially in breast cancer patients with anthracycline/cyclophosphamide (ас) chemotherapy. Netupitant/palonosetron (NEPA; Akynzeo®) is a fixed-dose combination of two drugs (netupitant, a neurokinin 1 receptor ant...

Full description

Saved in:
Bibliographic Details
Main Authors: A. G. Kedrova, A. I. Berishvili
Format: Article
Language:Russian
Published: ABV-press 2023-10-01
Series:Опухоли женской репродуктивной системы
Subjects:
netupitant
palonosetron
nepa
akynzeo
chemotherapy
breast cancer
vomiting
nausea
prevention
Online Access:https://ojrs.abvpress.ru/ojrs/article/view/1138
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items

Similar Items